#JACCHF
LightNews LightNews
cardioobdoc.bsky.social
Diuretic Potentiation Strategies in Acute Heart Failure

#CardioSky #MedSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @robmentz.bsky.social @sjgreene-md.bsky.social @vietheartpa.bsky.social @load-dependent.bsky.social @jimjanuzzi.bsky.social @dranulala.bsky.social
January 12, 2025 at 12:59 AM
jaccjournals.bsky.social
Stay connected & share your insights with the JACC Journals community by using our hashtags & tagging @jaccjournals.bsky.social:
📖 #JACC
🌟 #JACCAdvances
🌏 #JACCAsia
🔬 #JACCBTS
💙 #JACCCardioOnc
🩺 #JACCCaseReports
⚡️ #JACCCEP
❤️ #JACCHF
🩻 #JACCIMG
🚀 #JACCINT
📚 #JACCJournals
🎧 #JACCPodcast
💡 #JACCEdge
November 22, 2024 at 7:21 PM
cardioobdoc.bsky.social
Mineralocorticoid Antagonism in Heart Failure: Established & Emerging Therapeutic Role

#CardioSky #MedSky
#JACCHF
@jaccjournals.bsky.social @accintouch.bsky.social
@robmentz.bsky.social @hvanspall.bsky.social
www.jacc.org/doi/10.1016/...
December 9, 2024 at 2:03 AM
cardioobdoc.bsky.social
Management of Iron Deficiency in Heart Failure: Practical Considerations & Implementation of Evidence-Based Iron Supplementation

#CardioSky #JACCHF
@jaccjournals.bsky.social @robmentz.bsky.social @dranulala.bsky.social @hfsa.bsky.social @accintouch.bsky.social
www.jacc.org/doi/10.1016/...
December 9, 2024 at 8:58 PM
anastasiasmihaili.bsky.social
#CardioObstetrics

Women who experienced any of five major adverse #pregnancy 🤰outcomes have increased risk of #HeartFailure up to 46 years later & need early preventive actions & long-term clinical care to reduce that risk.

bit.ly/4jniTK6 #JACCHF @jaccjournals.bsky.social
Are Certain Adverse Pregnancy Outcomes Associated With Long-Term Increased Risk of HF? - American College of Cardiology
bit.ly
January 27, 2025 at 3:32 AM
accintouch.bsky.social
❤️ Heart Failure in focus at #ESCCongress. #JACCHF Editor-in-Chief Dr. Biykem Bozkurt highlights key science from Hot Line 2.

📺 Watch her Quick Takes now with #ACCAnywhere TV from ESC Congress in Madrid ⬇️
August 31, 2025 at 10:07 AM
cardioobdoc.bsky.social
Severe HF & Treatment With #Dapagliflozin Across Ejection Fraction Spectrum: DAPA-HF & DELIVER

#CardioSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @sjgreene-md.bsky.social @jimjanuzzi.bsky.social @hvanspall.bsky.social @vietheartpa.bsky.social @robmentz.bsky.social
March 9, 2025 at 1:31 PM
roddywalsh.bsky.social
A little editorial I wrote for #JACCHF on the challenges of identifying modifier genetic factors for hypertrophic cardiomyopathy. @jaccjournals.bsky.social authors.elsevier.com/a/1kCHM7tD%7... (<- free access link until Jan 21st) #cardiogen
Factors Associated With Phenotypic Variability in HCM
December 2, 2024 at 9:05 PM
hancardiomd.bsky.social
Efficacy, Safety and Mechanistic Impact of a #HeartFailure Guideline-Directed Medical Therapy Clinic

#JACCHF #CardioSky #GDMT

www.jacc.org/doi/full/10....

@jimjanuzzi.bsky.social @jaccjournals.bsky.social @drmarthagulati.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social
April 9, 2025 at 11:50 PM
novitham.bsky.social
Analysis of 1078 pts in #STRONG_HF:

📍Rapid #GDMT uptitration (~80% dose by day 90) is safe, feasible & ⬇️#HF readmissions/mortality in pts w/wo #AFib

📍#AFib shouldn’t be a barrier, all #HF pts deserve optimal care #GDMTworks

🔗 www.jacc.org/doi/full/10....

#JACCHF #Epeeps
@jaccjournals.bsky.social
December 2, 2024 at 3:16 AM
accintouch.bsky.social
DAPA-HF and DELIVER: Treatment of severe HF across the spectrum of #LVEF with the #SGLT2 inhibitor dapagliflozin appeared to be safe and effective in reducing the risk of CV death or worsening HF.

Read more: bit.ly/41FVcVc

#heartfailure #JACCHF #CardioSky #MedSky @jaccjournals.bsky.social
March 10, 2025 at 5:44 PM
cardioobdoc.bsky.social
Is #Aficamten Plus #Disopyramide More Effective Than Aficamten Alone in obstructive HCM?

#CardioSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @jimjanuzzi.bsky.social @robmentz.bsky.social @hvanspall.bsky.social @vietheartpa.bsky.social @load-dependent.bsky.social
May 9, 2025 at 3:30 AM
cardioob.bsky.social
Original Paper:
Adverse Pregnancy Outcomes & Long-Term Risk of HF in Women: National Cohort & Co-Sibling Study

#CardioSky #CardioObstetrics #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @csilvers.bsky.social @drklindley.bsky.social @isabellemalhame.bsky.social
January 27, 2025 at 6:46 PM
cardioobdoc.bsky.social
Revisiting ICD Therapy for Primary Prevention in Patients With #HFrEF
#JACCHF #SOTA

#CardioSky #MedSky #HeartFailure
@jaccjournals.bsky.social @jimjanuzzi.bsky.social @robmentz.bsky.social @dranulala.bsky.social @hfsa.bsky.social @dreprime.bsky.social
www.jacc.org/doi/full/10....
December 11, 2024 at 10:04 PM
codonnell1130.bsky.social
Happy to share our work developing a method for matching heart transplant donors-to-recipients using echo-derived donor left ventricular mass (LVM) for size matching which improved outcomes (especially in obese patients).
www.jacc.org/doi/10.1016/...

#JACCHF #echofirst #Cardiosky #Echosky #Medsky
The Association of Echocardiographically Measured Donor Left Ventricular Mass and 1-Year Outcomes After Heart Transplantation:
www.jacc.org
December 5, 2024 at 10:45 PM
thaithanhnha.bsky.social
Beyond Guideline-Directed Medical Therapy: Nonpharmacologic Management for Patients With Heart Failure.

www.jacc.org/doi/10.1016/...

@jaccjournals.bsky.social
#CardioSky #MedSky #HeartFailure #JaccHF
February 16, 2025 at 2:39 PM
jaccjournals.bsky.social
New study in #JACCHF on growth hormone (GH) replacement in patients with GH deficiency + #HFrEF
🔸 Improved exercise capacity + #QoL in GH replacement vs controls
🔸 Impetus here to screen for GH more, consider in those with residual symptoms despite #GDMT

📎: www.jacc.org/doi/10.1016/... #CardioSky
Growth Hormone Replacement Therapy in Heart Failure With Reduced Ejection Fraction: A Randomized, Double-Blind, Placebo-Controlled Trial
www.jacc.org
May 1, 2025 at 7:31 PM
cardioobdoc.bsky.social
Functional Status & Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes & Outcomes

🦋 6MWD + MLWHFQ were associated with MACE independent of Mayo Stage

#CardioSky #MedSky
#JACCHF
@jaccjournals.bsky.social @anastasiasmihaili.bsky.social
www.jacc.org/doi/10.1016/...
December 12, 2024 at 2:41 AM
docbhardwaj.bsky.social
📣 The 2023 @accintouch.bsky.social #AHF Staffing Survey is out!

Curious about current staffing trends in #HT #LVAD programs across the U.S.?
Check out the latest data and see how things have evolved over time.

@jaccjournals.bsky.social #JACCHF

👉 www.jacc.org/doi/10.1016/...
The 2023 American College of Cardiology Advanced Heart Failure Staffing Survey: The Report From the ACC Council on Heart Failure and Transplantation
www.jacc.org
April 11, 2025 at 5:21 AM
jaccjournals.bsky.social
Townhall discussion offering the audience the opportunity to ask their burning questions about the practical optimization of #heartfailure management in the real world

📍s100a

#ACC25 #JACCHF
March 29, 2025 at 6:45 PM
jaccjournals.bsky.social
Between 2021-2025, relatively few AHFTC fellowship programs matched most applicants. Applicants prioritize markers of hospital reputation & #Hearttx volumes over regional disease burden or geographical considerations. https://bit.ly/4nHnWXP

#HFSA2025 #JACCHF #ACCHFT @eirangorodeski.bsky.social
September 26, 2025 at 6:30 PM
jaccjournals.bsky.social
#NYValves2025 brings together leaders in structural heart disease: interventionalists, imagers, surgeons & HF specialists.

📚 Browse groundbreaking #JACCJournals research published to coincide with meeting presentations 👉 www.jacc.org/events/confe...

#JACC #JACCINT #JACCIMG #JACCHF #JACCCaseReports
June 25, 2025 at 5:40 PM
jaccjournals.bsky.social
MAPLE-HCM: #Aficamten was superior to metoprolol regardless of baseline BB use or prior SOC therapy, supporting the primary results and suggesting no confounding by BB resistance. Aficamten may be considered an early treatment option. https://bit.ly/4qAJhnK

#ESCCongress #JACCHF #CardioSky #oHCM
August 29, 2026 at 2:35 PM
kbrjbr.bsky.social
Important article for patients with HF!

www.jacc.org/doi/10.1016/...

@jaccjournals.bsky.social
#CardioSky #MedSky #HeartFailure #JaccHF
February 16, 2025 at 4:43 PM
jaccjournals.bsky.social
#THT2025 #JACCHF LBCT: In patients with #heartfailure & #LVEF >40%, APTURE shunt confirmed acceptable safety profile with improvements in HF symptoms, #QoL, & functional capacity without negatively affecting right & left heart function after 2 years, regardless of PVD www.jacc.org/doi/10.1016/...
February 11, 2025 at 3:54 PM